FDA 483 Database
FDA Form 483s Issued in April 2021
Every published Form FDA 483 issued in April 2021, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
5
Published 483s in April 2021
5
Distinct firms
Form 483s issued in April 2021
BPI Labs LLCFDA
- FEI
- 3015156709
- Issued
- Apr 30, 2021
- Establishment
- Sterile Drug Manufacturer
- Location
- Florida, United States
Wuxi BiologicsFDA
- FEI
- 3010606982
- Issued
- Apr 2, 2021
- Establishment
- Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
- Location
- China
Age Management Institute Santa BarbaraFDA
- FEI
- 3018101540
- Issued
- Apr 12, 2021
- Establishment
- Producer of Sterile Drug Products
- Location
- California, United States
Fujifilm Diosynth Biotechnologies USAFDA
- FEI
- 3000718852
- Issued
- Apr 21, 2021
- Establishment
- Active Pharmaceutical Ingredient Manufacturer
- Location
- United States
Emergent Manufacturing Operations Baltimore, LLC.FDA
- FEI
- 3015448605
- Issued
- Apr 20, 2021
- Establishment
- Vaccine Manufacturer
- Location
- Maryland, United States
| Company | FEI | Establishment type | Location | Issued | Source |
|---|---|---|---|---|---|
| BPI Labs LLC | 3015156709 | Sterile Drug Manufacturer | Florida, United States | Apr 30, 2021 | FDA |
| Wuxi Biologics | 3010606982 | Active Pharmaceutical Ingredient & Finished Dosage Manufacturer | China | Apr 2, 2021 | FDA |
| Age Management Institute Santa Barbara | 3018101540 | Producer of Sterile Drug Products | California, United States | Apr 12, 2021 | FDA |
| Fujifilm Diosynth Biotechnologies USA | 3000718852 | Active Pharmaceutical Ingredient Manufacturer | United States | Apr 21, 2021 | FDA |
| Emergent Manufacturing Operations Baltimore, LLC. | 3015448605 | Vaccine Manufacturer | Maryland, United States | Apr 20, 2021 | FDA |